N6022

· Nivalis Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for N6022, covering 2014-03-07 to 2015-01-19. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study Evaluating N6022 in Multiple-Ascending Doses in Healthy Subjects [Phase 1]